The top U.S. public health agency said Friday that in-person schooling can resume safely with masks, social distancing and other strategies, and that vaccination of teachers, while important, is not a prerequisite for reopening schools.
The top U.S. public health agency said Friday that in-person schooling can resume safely with masks, social distancing and other strategies, and that vaccination of teachers, while important, is not a prerequisite for reopening schools.
The "Automotive Electric Drive Axle - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The global point of care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public sectors boosting the research activities are likely to have effect in the growth of point of care diagnostics market. However, lack of proper alignment of POCs with central lab methods, and lower adoption, due to lack of knowledge regarding the use of PoC products for indicative diseases in many low resource economies are likely to hamper the growth of this market. The recent COVID-19 global pandemic has also impacted the point of care diagnostics market. Demand from the main end-users has increased as key regions and countries demanded for rapid testing kits in order to detect the COVID infection at the earliest. The rapidly growing number of COVID-19 cases and the growing pressure on governments to improve patient management has boosted the demand for rapid testing kits that can be effectively used in point-of-care settings. The glucose monitoring products segment to witness the highest growth rate in point of care diagnostics market, by product, during the forecast period. The glucose monitoring products segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of diabetes, ongoing technological advancements in blood glucose self-monitoring devices, and growing patient awareness about the availability POC products to easily monitor blood glucose level at home. The lateral flow assays segment accounted for the largest share of the point of care diagnostics market, by platform, in 2020. The lateral flow assays segment accounted for the largest share of the point of care diagnostics market in 2020. The increasing adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures are playing a critical factor supporting the growth of this segment. The OTC testing segment accounted for the largest share of the point of care diagnostics, by mode of purchase, in 2020"OTC testing products are used for glucose monitoring, pregnancy & fertility testing, infectious disease testing, and cholesterol-level testing. Moreover, many PoC devices available without prescription in many developing nations and increase in online purchase of OCT POC product are driving the demand for OTC POC testing products. The Hospitals & Critical Care Centers segment accounted for the largest share of the point of care diagnostics, by end users, in 2020 Hospitals and clinics make use of POC devices for improving patient care and treatment efficiency. One of the main advantages of using POC devices in hospitals or clinical settings over laboratory tests is that they have a faster turnaround time for testing as compared to a laboratory. Increase in the awareness of the benefits associated with the POC diagnostics for the treatment/monitoring of various patients in hospitals/critical care centers are accelerating the use of POC devices among these end users. The Asia Pacific market to grow at the highest CAGR during the forecast period. The point of care diagnostics market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related rapid diagnostic devices at point of care , rising healthcare expenditure, increasing healthcare expenditures, increasing number of hospitals and clinical diagnostic laboratories in India and China, and growing collaborations among players in the region are also expected to drive point of care diagnostics market growth in Aisa Pacific Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Point-Of-Care Diagnostics Market Overview4.2 Point-Of-Care Diagnostics Market, by Mode of Purchase, 20204.3 Asia-Pacific: Point-Of-Care Diagnostics Market4.4 Point-Of-Care Diagnostics Market, by Region 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers220.127.116.11 High Prevalence of Infectious Diseases18.104.22.168 Increasing Incidence of Target Conditions22.214.171.124 Supportive Government Policies126.96.36.199 Dearth of Skilled Laboratory Technicians188.8.131.52 Rising Number of Clia-Waived Poc Tests5.2.2 Restraints184.108.40.206 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints220.127.116.11 Stringent Regulatory Policies5.2.3 Opportunities18.104.22.168 Emerging Markets22.214.171.124 Healthcare Decentralization126.96.36.199 Increasing Provider Awareness About Novel Technologies188.8.131.52 Poc Tests with Multiplexing Capabilities184.108.40.206 Growing Investments and Funding for Product Development5.2.4 Challenges220.127.116.11 Lack of Alignment with Definitive Central Lab Methods18.104.22.168 Inadequate Adoption of Poc Devices in Professional Settings22.214.171.124 Reluctance to Change Existing Diagnostic Practices126.96.36.199 Premium Pricing of Novel Platforms5.3 Technology Analysis: Emerging Point-Of-Care Applications5.3.1 Sepsis Biomarkers5.3.2 Stroke/Cardiac Markers5.3.3 Thyroid Testing5.3.4 DNA Testing5.3.5 Endocrine Testing5.3.6 Respiratory Diagnostics5.4 Global Regulatory Landscape5.5 Industry Trends Related to COVID-195.6 Value Chain Analysis5.7 Pricing Trend Analysis5.8 Ecosystem Coverage: Parent Market (In Vitro Diagnostics)5.9 Use Cases: Point-Of-Care Diagnostics Market5.9.1 Revenue Opportunities: IVD Assay Development Services5.9.2 Revenue Opportunities: IVD Contract Research Services 6 Point-Of-Care Diagnostics Market, by Product6.1 Introduction6.2 Glucose Monitoring Products6.3 Cardiometabolic Monitoring Products6.4 Infectious Disease Testing Products6.5 Coagulation Monitoring Products6.6 Pregnancy & Fertility Testing Products6.7 Tumor/Cancer Marker Testing Products6.8 Urinalysis Testing Products6.9 Cholesterol Testing Products6.10 Hematology Testing Products6.11 Drugs-Of-Abuse Testing Products6.12 Fecal Occult Testing Products6.13 Other Poc Products 7 Point-Of-Care Diagnostics Market, by Platform7.1 Introduction7.2 Lateral Flow Assays7.2.1 Technological Advancements and Increasing Adoption of LFA Are Supporting Market Growth7.3 Immunoassays7.3.1 Rising Incidence of Cancer and Growing Awareness About Immunoassay Platforms to Support Market Growth7.4 Microfluidics7.4.1 Microfluidics is An Emerging Platform in the Poc Diagnostics Market7.5 Dipsticks7.5.1 Dipsticks Help in the Routine Analysis of Several Medical Conditions7.6 Molecular Diagnostics7.6.1 Increasing Initiatives by Market Players for Developing Poc Molecular Diagnostic Products to Drive Market Growth 8 Point-Of-Care Diagnostics Market, by Mode of Purchase8.1 Introduction8.2 OTC Testing Products8.2.1 Rising Focus on Home Care is Expected to Boost the Demand for OTC Testing in the Coming Years8.3 Prescription-Based Testing Products8.3.1 Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth 9 Point-Of-Care Diagnostics Market, by End-user9.1 Introduction9.2 Outpatient & Ambulatory Care Facilities9.2.1 Rapid Result Generation and Availability of Immediate Patient Care Are the Major Factors Driving Market Growth9.3 Hospitals & Critical Care Centers9.3.1 Hospitals Are Among the Largest End-users of Poc Diagnostics9.4 Home Care Settings9.4.1 Increasing Inclination Toward Home Healthcare is Driving the Growth of this End-User Segment9.5 Other End-users 10 Point-Of-Care Diagnostics Market, by Region10.1 Introduction10.2 North America10.3 Europe10.4 Asia-Pacific10.5 Latin America10.6 Middle East & Africa 11 Competitive Landscape11.1 Overview11.2 Market Share Analysis (2019)11.3 Competitive Scenario (2016-2020)11.3.1 Key Product Launches & Product Approvals (2016-2020)11.3.2 Key Acquisitions (2016-2020)11.3.3 Key Agreements, Contracts, and Partnerships (2016-2020)11.4 Competitive Leadership Mapping: Major Global Players (As of 2019)11.4.1 Stars11.4.2 Emerging Leaders11.4.3 Pervasive Players11.4.4 Participants11.5 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (As of 2019)11.5.1 Progressive Companies11.5.2 Starting Blocks11.5.3 Responsive Companies11.5.4 Dynamic Companies 12 Company Profiles12.1 Roche Diagnostics12.2 Siemens Healthineers12.3 Danaher Corporation12.4 Becton, Dickinson and Company12.5 Abbott Laboratories12.6 Quidel Corporation12.7 Chembio Diagnostics12.8 Johnson & Johnson12.9 EKF Diagnostics12.10 Trinity Biotech12.11 Accubiotech12.12 Instrumentation Laboratory (A Werfen Company)12.13 Nova Biomedical12.14 PTS Diagnostics12.15 Sekisui Diagnostics12.16 Fluxergy 13 Appendix13.1 Discussion Guide13.2 Knowledge Store: The Subscription Portal13.3 Available Customizations13.4 Related Reports13.5 Author Details For more information about this report visit https://www.researchandmarkets.com/r/6h1pct CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
PV Nano Cell Roll-to-roll printing of temperature sensors using PV Nano Cell Sicrys™ I50TM-119 silver ink on PET substrate, with MicroFlex R2R system (Ricoh MH5421MF). Print width: 54.1 mm. PV Nano Cell Inkjet-printed humidity and temperature sensors using PV Nano Cell Sicrys™ I50TM-119 silver ink. Printed by TUC. MIGDAL HA’EMEK, Israel, March 03, 2021 (GLOBE NEWSWIRE) -- PV Nano Cell Ltd. (OTC: PVNNF), (the “Company”), an innovative provider of inkjet-based conductive digital printing solutions and producer of conductive digital inks, today announced that its Sicrys™ conductive ink was successfully used in Roll-to-Roll (R2R) continues inkjet printing of electronics as part of the DigiMan project. PV Nano Cell project partners were: C.P.C Solutions Ltd., Fraunhofer IKTS and Fraunhofer ENAS, Kerafol Keramische Folien GmbH & Co. KG, RIIT Ltd. OSTEC Group, Technical University of Chemnitz and MEPhI. The DigiMan Project (December 2018 – November 2020) developed innovative sensor platforms for agro-industrial applications by providing a digital manufacturing process based on printing technologies and nano-material inks. Such approach enables to miniaturize the sensors, achieve flexibility in the target sensor properties and to realize these sensors in economically affordable batches. As part of the project, Low-cost temperature and humidity sensors were realized in a roll-to-roll industrial inkjet printing system with nano silver inks on PET substrate, demonstrating the ability to print a large quantity of sensors with high yield. Furthermore, a Bluetooth based wireless communication board with an inkjet-printed silver antenna as well as a printed RFID NFC sensor tag were developed for wireless sensor communication. Photos accompanying this announcement are available at:https://www.globenewswire.com/NewsRoom/AttachmentNg/691be4e0-1a5d-4b72-8f82-5171a034fcbe https://www.globenewswire.com/NewsRoom/AttachmentNg/bd506c2f-2769-4fdc-89a8-495ea336a4ac PV Nano Cell’s Chief Executive Officer, Dr. Fernando de la Vega, commented, “The success of DigiMan project marks yet another valuable advancement of PV Nano Cell in demonstrating the validity of our complete digital conductive printing solutions for mass production applications. Special sensors were developed and printed with our conductive Sicrys™ inks in a roll-2-roll inkjet and sintering system. This achievement proves the complete solution approach of inks, printers and printing process can be utilized in mass-production roll-to-roll systems, a must for some of the high-volume applications”. About PV Nano CellPV Nano Cell (PVN) offers the first-ever complete solution for mass-produced inkjet based, printed electronics. The proven solution includes PVN’s proprietary Sicrys™, silver-based conductive inks, inkjet production printers and the complete printing process. The process includes ink properties' optimization, printer’s parameters setup, printing modifications & tailored printing instructions per application. In the heart of PVN’s value proposition lies its unique and patented conductive silver and coper inks - Sicrys™. Those are the only inks made of Single Nano Crystals – which allows the inks to have the highest stability and throughput required to drive optimal mass-production results for wide range of applications. PVN’s solutions are used all over the world in a range of digital printing applications including: photovoltaics, printed circuit boards, flexible printed circuits, antennas, sensors, heaters, touchscreens and other. For more information, please visit http://www.pvnanocell.com/ About Fraunhofer ENASThe Fraunhofer Institute for Electronic Nano Systems ENAS is the specialist and development partner in the field of Smart Systems and their integration for various applications. Fraunhofer ENAS has specialized on the challenge of combining micro and nano sensors, actuators and electronic components with interfaces for communication and a self-sufficient energy supply to form smart systems, thus supporting the Internet of Things and the ongoing digitalization. Fraunhofer ENAS develops single components, manufacturing technologies and system concepts, system integration technologies and actively supports the technology transfer for and with its customers. Whether Start-up, SME or large enterprise, Fraunhofer ENAS offers innovation consulting and supports customer projects, starting from the idea, via design and technology development or realization based on established technologies up to tested prototypes. If standard components do not meet the requirements, Fraunhofer ENAS provides expert assistance in the realization of innovative and marketable products. For more information, please visit https://www.enas.fraunhofer.de/ About TUCChemnitz University of Technology (German: Technische Universität Chemnitz, abbreviated TU Chemnitz) is a public university in Chemnitz, Germany. With over 11,000 students, it is the third largest university in Saxony. With approximately 1,500 employees in science, engineering and management, TU Chemnitz counts among the most important employers in the region. TU Chemnitz has many years of experience in the field of manufacturing smart objects and components in "sheet-to-sheet" and "roll-to-roll" manufacturing processes using various printing technologies: screen, gravure, and inkjet printing. For more information, please visit https://www.tu-chemnitz.de/index.html About DigiMan ProjectDigiMan was a project financed by MANUNET under the European Union’s Horizon 2020 research and innovation program. The objective of the DigiMan project was the development of a digital manufacturing process chain based on printing technologies and nanomaterial-based ink formulations for the development of smart sensors and hybrid electronics in different fields of applications. The project developed innovative ceramic- and polymer / paper-based sensor platforms that can be fabricated with environmentally friendly digital additive manufacturing technologies using inkjet or aerosol jet. This makes it possible to miniaturize the sensors, to achieve a flexibility in the target sensor properties and to realize these sensors in economically low cost even for small sensor batch quantities. For more information, please visit https://www.digiman-project.eu/Forward–looking StatementsThis press release contains forward–looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward–looking statements." All information set forth in this news release, except historical and factual information, represents forward–looking statements. This includes all statements about the Company's plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward–looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company operates; the ability to obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new business, and sign new agreements. For a more detailed description of the risks and uncertainties affecting PV Nano Cell, reference is made to the Company's latest Annual Report on Form 20-F which is on file with the Securities and Exchange Commission (SEC) and the other risk factors discussed from time to time by the Company in reports filed with, or furnished to, the SEC. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Emerging Markets Consulting, LLCMr. James S. Painter IIIPresidentw: 1 (321) 206-6682m: 1 (407) 340-0226f: 1 (352) 429-0691email: email@example.com website: www.emergingmarketsllc.com PV Nano Cell Ltd Dr. Fernando de la Vega CEO w: 972 (04) 654-6881 f: 972 (04) 654-6880email: firstname.lastname@example.org: www.pvnanocell.com
For 17 years, trucker Colin Birch has been hitting the highways to collect used cooking oil from restaurants. He works for Vancouver-based renderer West Coast Reduction Ltd, which processes the grease into a material to make renewable diesel, a clean-burning road fuel. Birch is caught between soaring demand for the fuel - driven by U.S. and Canadian government incentives - and scarce cooking oil supplies, because fewer people are eating out during the coronavirus pandemic.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) ("HempFusion" or the "Company"), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom's Regulatory Food Safety Agency (the "FSA").
The "Medical Foams - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
In this video clip from Motley Fool Live, recorded on Feb. 18, Fool.com contributors Brian Feroldi, Brian Withers, and Matt Frankel, CFP, discuss how to sleep soundly even when your portfolio loses $10,000 over the course of a few days. Matt Frankel: I see a question that I'd really like to address because it's a very important concept.
FRISCO, TX, March 03, 2021 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE: CRK) announced today that, subject to market conditions, it intends to offer an additional $250.0 million aggregate principal amount of its 6.75% senior notes due in 2029 (the "Notes") in a private placement to eligible purchasers. The Notes are a further issuance of the 6.75% senior notes due 2029, of which $1.0 billion aggregate principal amount are expected, subject to customary closing conditions, to be issued on March 4, 2021 (the "2029 Notes"). The Notes will be treated as a single series with the 2029 Notes under the indenture governing the 2029 Notes and will have the same terms as the 2029 Notes (other than the initial offering price). The Notes will have the same CUSIP numbers and will trade interchangeably with the 2029 Notes. The Company expects the Notes and the 2029 Notes to be fungible for U.S. federal income tax purposes. Comstock intends to use the net proceeds from this offering of the Notes to fund an anticipated increase in the aggregate maximum tender amount in the Company’s existing tender offers for a portion of the Company's 7.5% Senior Notes due 2025 and 9.75% Senior Notes due 2026 and pay fees and expenses in connection therewith. The Notes to be offered have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws and unless so registered, the Notes may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Notes being offered are expected to be eligible for trading by qualified institutional buyers under Rule 144A and non-U.S. persons outside the United States under Regulation S. This press release is being issued pursuant to Rule 135c under the Securities Act, and is neither an offer to sell nor a solicitation of an offer to buy the Notes or any other securities and shall not constitute an offer to sell or a solicitation of an offer to buy, or a sale of, the Notes or any other securities in any jurisdiction in which such offer, solicitation or sale is unlawful. About Comstock Resources Comstock Resources is a leading independent natural gas producer with operations focused on the development of the Haynesville shale in North Louisiana and East Texas. The Company's stock is traded on the New York Stock Exchange under the symbol CRK. This press release may contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties which could cause actual results to differ materially from those described herein. Although the Company believes the expectations in such statements to be reasonable, there can be no assurance that such expectations will prove to be correct. The Company’s Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K, and other SEC filings discuss important risk factors that could affect the Company’s business, results of operations and financial condition. The forward-looking statements in this news release speak only as of this date. Comstock does not undertake any obligation to revise or update publicly any forward-looking statement. CONTACT: Ron Mills Vice President - Finance & Investor Relations Comstock Resources 972-668-8834 email@example.com
The "Volumetric Displays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
(Bloomberg) -- European Central Bank policy makers see no need for drastic action to combat rising bond yields, believing the risk to the economy is manageable with verbal interventions and the flexibility of their asset-purchase program, according to officials familiar with internal discussions.While multiple Governing Council members have spoken out to say that higher yields may be unwarranted and could undermine the euro zone as it struggles with extended pandemic lockdowns, there is no sense of panic, the officials said.A step such as expanding the overall size of their 1.85 trillion-euro ($2.24 trillion) emergency bond-buying program is currently unnecessary, they said. They didn’t say whether the pace of purchases has been stepped up in recent days, using the much-touted flexibility of the tool.One official noted that yields fell on Monday after some policy makers said the ECB would react against unwarranted increases.An ECB spokesman declined to comment.“We should keep a close eye on developments and analyze the reasons. We are of course capable of flexibly adjusting the volume of PEPP implementation at any moment,” Bundesbank President Jens Weidmann said on Wednesday at a press conference, when asked about rising yields. “But in my view there has been no radical deterioration of financing conditions.”German bonds fell on Wednesday, led by the longest-dated debt, with 10-year yields rising as much as four basis points to minus 0.31%, before paring. The euro climbed 0.1%, before reversing gains to trade 0.2% lower at $1.2071.Executive Board member Fabio Panetta addressed the topic on Tuesday, saying the jump in government-bond yields “is unwelcome and must be resisted.” He also said it is “not too late” to act.A day earlier, French Governing Council member Francois Villeroy de Galhau said that the ECB “can and must react” to any unwarranted moves threatening to undermine the economy. Vice President Luis de Guindos argued that it’s important to understand why bond yields have risen, and said officials “have the flexibility that is needed in order to react.”More policy makers are scheduled to speak on Wednesday, including Bank of Spain Governor Pablo Hernandez de Cos as well as Guindos.Yields on euro-area debt have risen since mid-February, when expectations for reflation kicked a global bond selloff into high gear. Greek and Italian 10-year yields led the charge, climbing about 20 basis points in the past two weeks.Core European debt was also ensnared, with benchmark German yields climbing to levels last seen in March 2020 and French yields turning positive for the first time since June.Higher government bond yields pose a problem for the euro area because they are used by banks as a reference point for lending. The region’s recovery is already expected to be slower than that of many other advanced economies, in part due to its slow vaccine roll-out, and higher borrowing costs could further damp momentum.Yields are being pushed up by a global sell-off of longer-term government bonds originating in the U.S. where prospects of another dose of massive fiscal stimulus are bolstering the economy.Fire FightingFigures published this week surprised investors by showing that the central bank actually slowed purchasing last week, despite President Christine Lagarde saying policy makers are “closely monitoring” the rise in nominal bond yields.Those figures don’t reflect orders made Thursday and Friday, as transactions take a couple of days to settle and show up in the central bank’s accounts. This week’s purchasing data will be published next Monday and Tuesday.Investors have been closely watching for any signs of market intervention by the ECB. Vincent Juvyns, a strategist at JPMorgan Asset Management, said on Bloomberg radio that in contrast to the U.S., where the economy is being boosted by massive stimulus, “it is probably too early to allow rates to rise in Europe.”“I would hope and expect that the ECB would be a bit fire-fighting with additional buying in the coming weeks and months,” he said.(Updates with Weidmann comment in sixth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dublin, March 03, 2021 (GLOBE NEWSWIRE) -- The "Behavioral Health Software: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report investigates the behavioral health software market. This report also highlights current and future market potential along with a detailed analysis of the competitive environment, product advancements and dynamics such as market drivers and factors restraining market growth. The report also covers market projections through 2025 and includes company profiles. The report details segments such as by treatment type and geographical region. For market estimates, data have been provided for 2019 as the base year, with projections for 2020 and 2025. The behavioral health software market is evolving rapidly due to the increasing investment in this segment, which offers proven benefits and broad services for mental health. Behavioral health software helps improve a practice's workflows by decreasing administrative tasks such as documenting, appointment scheduling and billing. This will create positive impacts for practices and enhance care delivery. Report Includes: An overview of the global markets for behavioral health softwareMarket share analysis of the behavioral health software market based on type of component, function, end-users and regionEvaluation of current market trends, market size, market forecast, and detailed analysis of drivers, challenges, and opportunities affecting the market growthA look at the available treatment options, and technological advancements in the pipeline and upcoming methods for the maintenance of this conditionCoverage of key market developments and major advantages of behavioral health software Key Topics Covered: Chapter 1 Introduction Study Goals and ObjectivesReasons for Doing This StudyScope of This ReportInformation SourcesMethodologyGeographic BreakdownAnalyst's CredentialsRelated Reports Chapter 2 Summary and Highlights Highlights Chapter 3 Technology Background and Market Dynamics Technology BackgroundOverviewMarket DynamicsMarket DriversMarket Restraints Chapter 4 Market Breakdown by Component Type SoftwareMarket Size and ForecastSupportMarket Size and Forecast Chapter 5 Market Breakdown by Function ClinicalMarket Size and ForecastAdministrativeMarket Size and ForecastFinancialMarket Size and Forecast Chapter 6 Market Breakdown by End User Healthcare FacilitiesMarket Size and ForecastPayersMarket Size and ForecastPatientsMarket Size and Forecast Chapter 7 Market Breakdown by Region North AmericaMarket Size and ForecastEuropeMarket Size and ForecastAsia-PacificMarket Size and ForecastMiddle East and AfricaMarket Size and ForecastSouth AmericaMarket Size and Forecast Chapter 8 Company Profiles Accumedic Computer Systems Inc.Bestnotes LlcCerner Corp. For more information about this report visit https://www.researchandmarkets.com/r/tifb4g CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Executive Summary According to a research report published by Azoth Analytics, the global Choline Chloride Market in terms of Value was USD 614. 28 Million and in terms of Volume 595.New York, March 03, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Choline Chloride Market (Value, Volume) – Analysis By Form, End-User, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)" - https://www.reportlinker.com/p06030138/?utm_source=GNW 65 Thousand Tonnes in year 2020 with Asia Pacific leading the regional market share. Increasing consumption of poultry meat and egg, growing demand for meats in the Asia-Pacific region, and increasing awareness for feed supplements among the end-users are major factors driving the growth of the choline chloride market. Rising disposable income coupled with better standard of living has increased the consumption of poultry which in turn is expected to boost the overall demand for the choline chloride market.Furthermore, the vitality of choline chloride for the healthy functioning of the liver, proper brain development, muscle movement, better metabolism, and healthy nervous system, is anticipated to increase its demand as an essential supplement in the human nutrition industry.Among the Forms in the Choline Chloride market (Powder and Liquid), Liquid segment leads the market. Liquid choline chloride is a colorless, odorless, clear substance which is soluble in water, non-corrosive and non-toxic in nature. The product is extensively adopted in poultry feed industry on account of its ability to enhance growth and performance, nutrient utilization, fat metabolism and improves reproductive ability in animals. The product helps prevent health disorders such as liver enlargement and leg deformity, also called perosis in chicks.Based on End-User (Animal Feed, Human Nutrition, Oil & Gas, Others), Animal Feed segment gains a considerable share. Choline Chloride is highly adopted by the feed industry as it is used to manufacture animal feed and aqua feed products. Choline chloride has been intensively used in animal feed and appears as a liquid solution with a concentration of 75% as this concentration is stable. The high importance of choline in the animal body, such as an important metabolite that is important for maintaining the cell structure in an animal’s body and other important characteristics, has been one of the primary factors for the upsurge of the choline chloride market.The Asia Pacific Region dominates the Choline Chloride market. The growth of the choline chloride market in the region is primarily attributed to the increasing demand for poultry meat and the expansion of the aquaculture industry. The growing demand for poultry meat in countries such as Japan, and China has led to the increasing demand for animal feed. High demand for choline chloride, along with growing population in this region, is creating a strong need for choline chloride market.Scope of the Report• The report analyses the Choline Chloride market By Value and By Volume.• The report analyses the Choline Chloride market by Form (Powder and Liquid).• The report analyses the Choline Chloride market by End-User (Animal Feed, Human Nutrition, Oil & Gas and Others).• The Global Choline Chloride Market has been analysed by Region (North America, Europe, and Asia Pacific) and by Country (United States, Canada, Germany, Italy, France, United Kingdom, China, Japan, India, South Korea).• Also, the attractiveness of the market has been presented by region, form and end-user. Also, trends, drivers, challenges of the industry has been analysed in the report.• The report tracks competitive developments, strategies and mergers & acquisitions. The companies analysed in the report include BASF, Jubilant Life Sciences Limited, Eastman Chemical Company, GHW International, Balchem Corporation, Kemin Industries, Pestell Group, Nuproxa Group of Companies, Be-Long Corporation and Nutreco.• The report presents the analysis of Choline Chloride market for the historical period of 2016-2020 and the forecast period of 2021-2026.Key Target Audience• Choline Chloride Manufacturers & Technology Providers• Traders, Importers, and Exporters• Raw Material Suppliers and Distributors• Research and Consulting Firms• Government and Research Organizations• Associations and Industry BodiesRead the full report: https://www.reportlinker.com/p06030138/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Companies are taking active steps to reduce emissions. HRS' pioneering Green Stay Initiative helps corporate hotel programs travel more sustainably.
Charlie Munger recently spoke at the Daily Journal Corporation's (NASDAQ: DJCO) annual shareholder meeting, and he didn't hold back his opinions on current stock market trends. In the video below, we'll take a look at five notable Munger quotes from the meeting, including why value investing won't go out style and how investors should approach diversifying their portfolio. Narrator: Charlie Munger, the famous investor and vice-chairman of Berkshire Hathaway, recently spoke at the Daily Journal Corporation's annual shareholder meeting, of which Munger is chairman of the board.
The small-business specialist posted great numbers in 2020, and investments in technology will be a key to future growth.
Coinbase recently filed its widely anticipated registration statement, offering a first glance at its financials before it goes public. Coinbase was recently valued at more than $100 billion in private market trading, meaning this could be the largest tech IPO since Facebook's in 2012. Here are nine numbers you will want to know about Coinbase before you buy shares.
The gloss has rather worn off in the last two games, with England befuddled by India’s spinners, but it remains in Root’s grasp to fly home with what he describes as a “monumental” achievement. Root has carried England’s batting. England have not reached 200 since he last reached 200.
Chances are, you'll realize that you have options when it comes to your bank account. Poor customer service is something you shouldn't put up with in general -- and especially not from your bank. In a recent study by The Ascent, about 97% of people ranked quality of customer service as an important bank feature.
Dom Bess has admitted he was surprised to be dropped from the England XI in India and says that it has been “tough to watch” the two matches he has missed but is in a “great space” to return to the side in Thursday’s final Test. Bess was dropped for Moeen Ali after the opening Test of this series, having taken 17 wickets at an average of 23 in three matches – all victories – this winter. England opted to pick a fourth seamer rather than Bess, a second spinner, in the Third Test, a decision they now accept backfired badly.
Roy Hodgson has backed Eberechi Eze to help Crystal Palace out of their attacking slump, but says the Eagles expect far more from the midfielder now. Eze, who signed from QPR for £19.5million last summer, made a flying start to life in the Premier League but has not been hitting the same heights of late. With Wilfried Zaha close to a return, but not available to face Manchester United on Wednesday night, Hodgson has backed Eze to help Palace find their spark going forward once more.